Capital Bank & Trust CO Biomarin Pharmaceutical Inc Transaction History

Capital Bank & Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $875 - $1,366	-11 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$71.37 - $96.85 $785 - $1,065	11 New	11 $1,000
Q4 2019 Feb 18, 2020	SELL	$64.27 - $86.37 $28,857 - $38,780	-449 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $10,043 - $11,737	125 Added 38.58%	449 $38,000
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $18,187 - $21,301	-216 Reduced 40.0%	324 $29,000
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $45,551 - $51,274	485 Added 881.82%	540 $52,000
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $4,180 - $5,446	55 New	55 $5,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.9B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Capital Bank & Trust CO with notifications on news.